Renaissance Technologies
ELOS

Renaissance Technologies’s Syneron Medical Ltd ELOS Stock Holding History

Renaissance Technologies’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-580,780
Closed -$6.36M – 3540
2017
Q2 		$6.36M Sell
580,780
-523,800
-47% -$5.74M 0.01% 1549
2017
Q1 		$11.7M Sell
1,104,580
-36,861
-3% -$357K 0.02% 1129
2016
Q4 		$9.59M Buy
1,141,441
+119,835
+12% +$939K 0.02% 1259
2016
Q3 		$7.32M Buy
1,021,606
+56,500
+6% +$393K 0.01% 1364
2016
Q2 		$7.42M Buy
965,106
+36,300
+4% +$259K 0.01% 1336
2016
Q1 		$6.79M Buy
928,806
+28,200
+3% +$202K 0.01% 1412
2015
Q4 		$6.94M Sell
900,606
-12,174
-1% -$92.8K 0.02% 1242
2015
Q3 		$6.53M Sell
912,780
-18,923
-2% -$182K 0.02% 1201
2015
Q2 		$9.89M Buy
931,703
+92,923
+11% +$1.09M 0.02% 958
2015
Q1 		$10.4M Buy
838,780
+303,813
+57% +$3.36M 0.02% 918
2014
Q4 		$4.99M Buy
534,967
+40,787
+8% +$393K 0.01% 1269
2014
Q3 		$4.95M Sell
494,180
-19,500
-4% -$198K 0.01% 1167
2014
Q2 		$5.3M Sell
513,680
-72,700
-12% -$786K 0.01% 1185
2014
Q1 		$7.3M Sell
586,380
-31,800
-5% -$377K 0.02% 1044
2013
Q4 		$7.6M Sell
618,180
-14,626
-2% -$152K 0.02% 948
2013
Q3 		$5.46M Sell
632,806
-72,774
-10% -$628K 0.01% 1110
2013
Q2 		$6.14M Buy
+705,580
New +$6.31M 0.02% 986

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Renaissance Technologies's ELOS Position: Q3 2017 in Review

Renaissance Technologies sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 580,780 shares — an estimated $6.36M sold.

Renaissance Technologies first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $11.7M in Q1 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Renaissance Technologies reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Renaissance Technologies sold 580,780 Syneron Medical Ltd shares in Q3 2017, an estimated $6.36M.
  • Renaissance Technologies first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Renaissance Technologies's Syneron Medical Ltd position peaked at $11.7M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.